The Patent Finder

Terms ending in 2032

ModernaTX, Inc.

Every in-force patent on ModernaTX, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,710,200Engineered Nucleic Acids Encoding a Modified Erythropoietin and Their Expression
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 9,186,372Split Dose Administration
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 9,533,047Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 9,950,068Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 10,898,574Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 11,911,474Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 12,364,763Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 12,409,226Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 12,419,957Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 12,502,431Delivery and Formulation of Engineered Nucleic Acids
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
3 more term ends in 2032 · Pro
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13.
Upgrade to Pro
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited